60 participants
A Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for SCLC
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-27
- Start Date:
- 2024-10-16
- Completion:
- 2026-06-30
Conditions
- Small-cell Lung Cancer
Interventions
- DRUG
No Results Yet